DOI QR코드

DOI QR Code

Prognostic Factors of Atypical Meningioma : Overall Survival Rate and Progression Free Survival Rate

  • Lee, Jae Ho (Department of Neurosurgery, Yeungnam University Medical Center, Yeungnam University College of Medicine) ;
  • Kim, Oh Lyong (Department of Neurosurgery, Yeungnam University Medical Center, Yeungnam University College of Medicine) ;
  • Seo, Young Beom (Department of Neurosurgery, Yeungnam University Medical Center, Yeungnam University College of Medicine) ;
  • Choi, Jun Hyuk (Department of Pathology, Yeungnam University Medical Center, Yeungnam University College of Medicine)
  • Received : 2017.03.31
  • Accepted : 2017.07.03
  • Published : 2017.11.01

Abstract

Objective : Atypical meningioma is rare tumor and there is no accurate guide line for optimal treatment. This retrospective study analyzed the prognostic factors, the effect of different methods of treatments and the behavior of atypical meningioma. Methods : Thirty six patients were diagnosed as atypical meningioma, among 273 patients who were given a diagnosis of meningioma in the period of 2002 to 2015. Age, gender, tumor location, Ki 67, Simpson grade and treatment received were analyzed. We studied the correlation between these factors with recurrence, overall survival rate and progression free survival. Results : Median overall survival time and progression free survival time are 60 and 53 (months). Better survival rate was observed for patients less than 50 years old but with no statistical significance (p=0.322). And patients with total resection compared with subtotal resection also showed better survival rate but no statistical significance (p=0.744). Patients with a tumor located in skull base compared with patients with a tumor located in brain convexity and parasagittal showed better progression free survival (p=0.048). Total resection is associated with longer progression-free survival than incomplete resection (p=0.018). Conclusion : We confirmed that Simpson grade was significant factor for statistically affect to progression free survival in univariate analysis. In case of skull base atypical tumor, it is analyzed that it has more recurrence than tumor located elsewhere. Overall survival was not affected statistically by patient age, gender, tumor location, Ki 67, Simpson grade and treatment received in this study.

Keywords

References

  1. Aghi MK, Carter BS, Cosgrove GR, Ojemann RG, Amin-Hanjani S, Martuza RL, et al. : Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64 : 56-60; discussion 60, 2009 https://doi.org/10.1227/01.NEU.0000330399.55586.63
  2. Akeyson EW, McCutcheon IE : Management of benign and aggressive intracranial meningiomas. Oncology (Williston Park) 10 : 747-756; discussion 756-759, 1996
  3. Bruna J, Brell M, Ferrer I, Gimenez-Bonafe P, Tortosa A : Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma. Neuropathology 27 : 114-120, 2007 https://doi.org/10.1111/j.1440-1789.2007.00750.x
  4. Cao X, Hao S, Wu Z, Wang L, Jia G, Zhang L, et al. : Treatment response and prognosis after recurrence of atypical meningiomas. World Neurosurg 84 : 1014-1019, 2015 https://doi.org/10.1016/j.wneu.2015.05.032
  5. Champeaux C, Wilson E, Brandner S, Shieff C, Thorne L : World Health Organization grade III meningiomas. A retrospective study for outcome and prognostic factors assessment. Br J Neurosurg 29 : 693-698, 2015 https://doi.org/10.3109/02688697.2015.1054350
  6. Chen WY, Liu HC : Atypical (anaplastic) meningioma: relationship between histologic features and recurrence--a clinicopathologic study. Clin Neuropathol 9 : 74-81, 1990
  7. Coke CC, Corn BW, Werner-Wasik M, Xie Y, Curran WJ Jr : Atypical and malignant meningiomas: an outcome report of seventeen cases. J Neurooncol 39 : 65-70, 1998 https://doi.org/10.1023/A:1005981731739
  8. Condra KS, Buatti JM, Mendenhall WM, Friedman WA, Marcus RB Jr, Rhoton AL : Benign meningiomas: primary treatment selection affects survival. Int J Radiat Oncol Biol Phys 39 : 427-436, 1997 https://doi.org/10.1016/S0360-3016(97)00317-9
  9. Dziuk TW, Woo S, Butler EB, Thornby J, Grossman R, Dennis WS, et al. : Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy. J Neurooncol 37 : 177-188, 1998 https://doi.org/10.1023/A:1005853720926
  10. Goyal LK, Suh JH, Mohan DS, Prayson RA, Lee J, Barnett GH : Local control and overall survival in atypical meningioma: a retrospective study. Int J Radiat Oncol Biol Phys 46 : 57-61, 2000 https://doi.org/10.1016/S0360-3016(99)00349-1
  11. Hug EB, Devries A, Thornton AF, Munzenride JE, Pardo FS, Hedley-Whyte ET, et al. : Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy. J Neurooncol 48 : 151-160, 2000 https://doi.org/10.1023/A:1006434124794
  12. Jo K , Park HJ, Nam DH, Lee JI, Kong DS, Park K , et al. : Treatment of atypical meningioma. J Clin Neurosci 17 : 1362-1366, 2010 https://doi.org/10.1016/j.jocn.2010.03.036
  13. Louis D, Scheithauer B, Budka H, Von Deimling A, Kepes J, Kleihues P, et al. : Pathology and genetics of tumors of the nervous system in Kleihues P, Cavenee WK (eds) : World Health Organization Classification of Tumours: Pathology and Genetics: Tumors of the Nervous System, ed 2. Lyon : IARC Press, 2000, Vol 1, pp176-184
  14. Mahmood A, Caccamo DV, Tomecek FJ, Malik GM : Atypical and malignant meningiomas: a clinicopathological review. Neurosurgery 33 : 955-963, 1993
  15. McCarthy BJ, Davis FG, Freels S, Surawicz TS, Damek DM, Grutsch J, et al. : Factors associated with survival in patients with meningioma. J Neurosurg 88 : 831-839, 1998 https://doi.org/10.3171/jns.1998.88.5.0831
  16. Modha A, Gutin PH : Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery 57 : 538-550; discussion 538-550, 2005 https://doi.org/10.1227/01.NEU.0000170980.47582.A5
  17. Palma L, Celli P, Franco C, Cervoni L, Cantore G : Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases. J Neurosurg 86 : 793-800, 1997 https://doi.org/10.3171/jns.1997.86.5.0793
  18. Park HJ, Kang HC, Kim IH, Park SH, Kim DG, Park CK, et al. : The role of adjuvant radiotherapy in atypical meningioma. J Neurooncol 115 : 241-247, 2013 https://doi.org/10.1007/s11060-013-1219-y
  19. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM : Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 21 : 1455-1465, 1997 https://doi.org/10.1097/00000478-199712000-00008
  20. Tomura N, Takahashi S, Sakuma I, Omachi K, Watarai J, Sasajima T, et al. : Neuroradiological findings of atypical meningiomas. CMIG Extra: Cases 28 : 33-39, 2004 https://doi.org/10.1016/j.compmedimag.2004.05.004
  21. Torp SH, Lindboe CF, Granli US, Moen TM, Nordtomme T : Comparative investigation of proliferation markers and their prognostic relevance in human meningiomas. Clin Neuropathol 20 : 190-195, 2001
  22. Zaher A, Abdelbari Mattar M, Zayed DH, Ellatif RA, Ashamallah SA : Atypical meningioma: a study of prognostic factors. World Neurosurg 80 : 549-553, 2013 https://doi.org/10.1016/j.wneu.2013.07.001

Cited by

  1. Factors Related to the Post-operative Recurrence of Atypical Meningiomas vol.10, pp.None, 2017, https://doi.org/10.3389/fonc.2020.00503
  2. A Novel Scoring System Based on Preoperative Routine Blood Test in Predicting Prognosis of Atypical Meningioma vol.10, pp.None, 2020, https://doi.org/10.3389/fonc.2020.01705
  3. Neurosurgical follow-up and treatment of a series of 26 WHO grade III meningiomas vol.91, pp.None, 2021, https://doi.org/10.1016/j.jocn.2021.06.047
  4. Treatment and follow-up results of WHO grade II meningiomas vol.91, pp.None, 2021, https://doi.org/10.1016/j.jocn.2021.07.022
  5. The 2016 Edition of the WHO Classification of Primary Brain Tumors: Applicable to Assess Individual Risk of Recurrence in Atypical Meningioma? A Single-Center Experience vol.82, pp.5, 2017, https://doi.org/10.1055/s-0040-1720987